Circulating tumor cells are cancer cells that have detached from the tumor and are found at extremely low levels in the bloodstream. The value of capturing and counting CTCs is evolving as more research data is gathered about the utility of these markers in monitoring disease progression and potentially guiding personalized cancer therapy.

Scope of the Report:

This report studies the Circulating Tumor Cell market status and outlook of Global and major regions, from angles of players, countries, product types and end industries; this report analyzes the top players in global market, and splits the Circulating Tumor Cell market by product type and applications/end industries.

The classification of Circulating Tumor Cells (CTCs) products includes CTC enrichment, CTC detection and CTC analysis, and the revenue proportion of CTC enrichment in 2016 is about 43.74%.

The global Circulating Tumor Cell market is valued at xx million USD in 2017 and is expected to reach xx million USD by the end of 2023, growing at a CAGR of xx% between 2017 and 2023.

The Asia-Pacific will occupy for more market share in following years, especially in China, also fast growing India and Southeast Asia regions.

North America, especially The United States, will still play an important role which cannot be ignored. Any changes from United States might affect the development trend of Circulating Tumor Cell.

Europe also play important roles in global market, with market size of xx million USD in 2017 and will be xx million USD in 2023, with a CAGR of xx%.

Market Segment by Companies, this report covers

Menarini-Silicon Biosystems

Qiagen（Adnagen）

Clearbridge Biomedics

Celsee

Fluidigm

ApoCell

Greiner Bio-one GmbH

Advanced Cell Diagnostics

Aviva Biosciences

Fluxion Biosciences

Sysmex Corporation

Epic Sciences

Cynvenio

CytoTrack

Ikonisys

Vortex BioSciences

Gilupi

Biocept

ScreenCell

ANGLE

Market Segment by Regions, regional analysis covers

North America (United States, Canada and Mexico)

Europe (Germany, France, UK, Russia and Italy)

Asia-Pacific (China, Japan, Korea, India and Southeast Asia)

South America (Brazil, Argentina, Colombia)

Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Market Segment by Type, covers

CTC Enrichment

CTC Detection

CTC Analysis

Market Segment by Applications, can be divided into

Breast Cancer

Prostate Cancer

Colorectal Cancer

Other

Table of Contents

1 Circulating Tumor Cell Market Overview

1.1 Product Overview and Scope of Circulating Tumor Cell

1.2 Classification of Circulating Tumor Cell by Types

1.2.1 Global Circulating Tumor Cell Revenue Comparison by Types (2017-2023)

1.2.2 Global Circulating Tumor Cell Revenue Market Share by Types in 2017

1.2.3 CTC Enrichment

1.2.4 CTC Detection

1.2.5 CTC Analysis

1.3 Global Circulating Tumor Cell Market by Application

1.3.1 Global Circulating Tumor Cell Market Size and Market Share Comparison by Applications (2013-2023)

1.3.2 Breast Cancer

1.3.3 Prostate Cancer

1.3.4 Colorectal Cancer

1.3.5 Other

1.4 Global Circulating Tumor Cell Market by Regions

1.4.1 Global Circulating Tumor Cell Market Size (Million USD) Comparison by Regions (2013-2023)

1.4.1 North America (USA, Canada and Mexico) Circulating Tumor Cell Status and Prospect (2013-2023)

1.4.2 Europe (Germany, France, UK, Russia and Italy) Circulating Tumor Cell Status and Prospect (2013-2023)

1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Circulating Tumor Cell Status and Prospect (2013-2023)

1.4.4 South America (Brazil, Argentina, Colombia) Circulating Tumor Cell Status and Prospect (2013-2023)

1.4.5 Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Circulating Tumor Cell Status and Prospect (2013-2023)

1.5 Global Market Size of Circulating Tumor Cell (2013-2023)

2 Manufacturers Profiles

2.1 Menarini-Silicon Biosystems

2.1.1 Business Overview

2.1.2 Circulating Tumor Cell Type and Applications

2.1.2.1 Product A

2.1.2.2 Product B

2.1.3 Menarini-Silicon Biosystems Circulating Tumor Cell Revenue, Gross Margin and Market Share (2016-2017)

2.2 Qiagen（Adnagen）

2.2.1 Business Overview

2.2.2 Circulating Tumor Cell Type and Applications

2.2.2.1 Product A

2.2.2.2 Product B

2.2.3 Qiagen（Adnagen） Circulating Tumor Cell Revenue, Gross Margin and Market Share (2016-2017)

2.3 Clearbridge Biomedics

2.3.1 Business Overview

2.3.2 Circulating Tumor Cell Type and Applications

2.3.2.1 Product A

2.3.2.2 Product B

2.3.3 Clearbridge Biomedics Circulating Tumor Cell Revenue, Gross Margin and Market Share (2016-2017)

2.4 Celsee

2.4.1 Business Overview

2.4.2 Circulating Tumor Cell Type and Applications

2.4.2.1 Product A

2.4.2.2 Product B

2.4.3 Celsee Circulating Tumor Cell Revenue, Gross Margin and Market Share (2016-2017)

2.5 Fluidigm

2.5.1 Business Overview

2.5.2 Circulating Tumor Cell Type and Applications

2.5.2.1 Product A

2.5.2.2 Product B

2.5.3 Fluidigm Circulating Tumor Cell Revenue, Gross Margin and Market Share (2016-2017)

2.6 ApoCell

2.6.1 Business Overview

2.6.2 Circulating Tumor Cell Type and Applications

2.6.2.1 Product A

2.6.2.2 Product B

2.6.3 ApoCell Circulating Tumor Cell Revenue, Gross Margin and Market Share (2016-2017)

2.7 Greiner Bio-one GmbH

2.7.1 Business Overview

2.7.2 Circulating Tumor Cell Type and Applications

2.7.2.1 Product A

2.7.2.2 Product B

2.7.3 Greiner Bio-one GmbH Circulating Tumor Cell Revenue, Gross Margin and Market Share (2016-2017)

2.8 Advanced Cell Diagnostics

2.8.1 Business Overview

2.8.2 Circulating Tumor Cell Type and Applications

2.8.2.1 Product A

2.8.2.2 Product B

2.8.3 Advanced Cell Diagnostics Circulating Tumor Cell Revenue, Gross Margin and Market Share (2016-2017)

2.9 Aviva Biosciences

2.9.1 Business Overview

2.9.2 Circulating Tumor Cell Type and Applications

2.9.2.1 Product A

2.9.2.2 Product B

2.9.3 Aviva Biosciences Circulating Tumor Cell Revenue, Gross Margin and Market Share (2016-2017)

2.10 Fluxion Biosciences

2.10.1 Business Overview

2.10.2 Circulating Tumor Cell Type and Applications

2.10.2.1 Product A

2.10.2.2 Product B

2.10.3 Fluxion Biosciences Circulating Tumor Cell Revenue, Gross Margin and Market Share (2016-2017)

2.11 Sysmex Corporation

2.11.1 Business Overview

2.11.2 Circulating Tumor Cell Type and Applications

2.11.2.1 Product A

2.11.2.2 Product B

2.11.3 Sysmex Corporation Circulating Tumor Cell Revenue, Gross Margin and Market Share (2016-2017)

2.12 Epic Sciences

2.12.1 Business Overview

2.12.2 Circulating Tumor Cell Type and Applications

2.12.2.1 Product A

2.12.2.2 Product B

2.12.3 Epic Sciences Circulating Tumor Cell Revenue, Gross Margin and Market Share (2016-2017)

2.13 Cynvenio

2.13.1 Business Overview

2.13.2 Circulating Tumor Cell Type and Applications

2.13.2.1 Product A

2.13.2.2 Product B

2.13.3 Cynvenio Circulating Tumor Cell Revenue, Gross Margin and Market Share (2016-2017)

2.14 CytoTrack

2.14.1 Business Overview

2.14.2 Circulating Tumor Cell Type and Applications

2.14.2.1 Product A

2.14.2.2 Product B

2.14.3 CytoTrack Circulating Tumor Cell Revenue, Gross Margin and Market Share (2016-2017)

2.15 Ikonisys

2.15.1 Business Overview

2.15.2 Circulating Tumor Cell Type and Applications

2.15.2.1 Product A

2.15.2.2 Product B

2.15.3 Ikonisys Circulating Tumor Cell Revenue, Gross Margin and Market Share (2016-2017)

2.16 Vortex BioSciences

2.16.1 Business Overview

2.16.2 Circulating Tumor Cell Type and Applications

2.16.2.1 Product A

2.16.2.2 Product B

2.16.3 Vortex BioSciences Circulating Tumor Cell Revenue, Gross Margin and Market Share (2016-2017)

2.17 Gilupi

2.17.1 Business Overview

2.17.2 Circulating Tumor Cell Type and Applications

2.17.2.1 Product A

2.17.2.2 Product B

2.17.3 Gilupi Circulating Tumor Cell Revenue, Gross Margin and Market Share (2016-2017)

2.18 Biocept

2.18.1 Business Overview

2.18.2 Circulating Tumor Cell Type and Applications

2.18.2.1 Product A

2.18.2.2 Product B

2.18.3 Biocept Circulating Tumor Cell Revenue, Gross Margin and Market Share (2016-2017)

2.19 ScreenCell

2.19.1 Business Overview

2.19.2 Circulating Tumor Cell Type and Applications

2.19.2.1 Product A

2.19.2.2 Product B

2.19.3 ScreenCell Circulating Tumor Cell Revenue, Gross Margin and Market Share (2016-2017)

2.20 ANGLE

2.20.1 Business Overview

2.20.2 Circulating Tumor Cell Type and Applications

2.20.2.1 Product A

2.20.2.2 Product B

2.20.3 ANGLE Circulating Tumor Cell Revenue, Gross Margin and Market Share (2016-2017)

3 Global Circulating Tumor Cell Market Competition, by Players

3.1 Global Circulating Tumor Cell Revenue and Share by Players (2013-2018)

3.2 Market Concentration Rate

3.2.1 Top 5 Circulating Tumor Cell Players Market Share

3.2.2 Top 10 Circulating Tumor Cell Players Market Share

3.3 Market Competition Trend

4 Global Circulating Tumor Cell Market Size by Regions

4.1 Global Circulating Tumor Cell Revenue and Market Share by Regions

4.2 North America Circulating Tumor Cell Revenue and Growth Rate (2013-2018)

4.3 Europe Circulating Tumor Cell Revenue and Growth Rate (2013-2018)

4.4 Asia-Pacific Circulating Tumor Cell Revenue and Growth Rate (2013-2018)

4.5 South America Circulating Tumor Cell Revenue and Growth Rate (2013-2018)

4.6 Middle East and Africa Circulating Tumor Cell Revenue and Growth Rate (2013-2018)

5 North America Circulating Tumor Cell Revenue by Countries

5.1 North America Circulating Tumor Cell Revenue by Countries (2013-2018)

5.2 USA Circulating Tumor Cell Revenue and Growth Rate (2013-2018)

5.3 Canada Circulating Tumor Cell Revenue and Growth Rate (2013-2018)

5.4 Mexico Circulating Tumor Cell Revenue and Growth Rate (2013-2018)

6 Europe Circulating Tumor Cell Revenue by Countries

6.1 Europe Circulating Tumor Cell Revenue by Countries (2013-2018)

6.2 Germany Circulating Tumor Cell Revenue and Growth Rate (2013-2018)

6.3 UK Circulating Tumor Cell Revenue and Growth Rate (2013-2018)

6.4 France Circulating Tumor Cell Revenue and Growth Rate (2013-2018)

6.5 Russia Circulating Tumor Cell Revenue and Growth Rate (2013-2018)

6.6 Italy Circulating Tumor Cell Revenue and Growth Rate (2013-2018)

7 Asia-Pacific Circulating Tumor Cell Revenue by Countries

7.1 Asia-Pacific Circulating Tumor Cell Revenue by Countries (2013-2018)

7.2 China Circulating Tumor Cell Revenue and Growth Rate (2013-2018)

7.3 Japan Circulating Tumor Cell Revenue and Growth Rate (2013-2018)

7.4 Korea Circulating Tumor Cell Revenue and Growth Rate (2013-2018)

7.5 India Circulating Tumor Cell Revenue and Growth Rate (2013-2018)

7.6 Southeast Asia Circulating Tumor Cell Revenue and Growth Rate (2013-2018)

8 South America Circulating Tumor Cell Revenue by Countries

8.1 South America Circulating Tumor Cell Revenue by Countries (2013-2018)

8.2 Brazil Circulating Tumor Cell Revenue and Growth Rate (2013-2018)

8.3 Argentina Circulating Tumor Cell Revenue and Growth Rate (2013-2018)

8.4 Colombia Circulating Tumor Cell Revenue and Growth Rate (2013-2018)

9 Middle East and Africa Revenue Circulating Tumor Cell by Countries

9.1 Middle East and Africa Circulating Tumor Cell Revenue by Countries (2013-2018)

9.2 Saudi Arabia Circulating Tumor Cell Revenue and Growth Rate (2013-2018)

9.3 UAE Circulating Tumor Cell Revenue and Growth Rate (2013-2018)

9.4 Egypt Circulating Tumor Cell Revenue and Growth Rate (2013-2018)

9.5 Nigeria Circulating Tumor Cell Revenue and Growth Rate (2013-2018)

9.6 South Africa Circulating Tumor Cell Revenue and Growth Rate (2013-2018)

10 Global Circulating Tumor Cell Market Segment by Type

10.1 Global Circulating Tumor Cell Revenue and Market Share by Type (2013-2018)

10.2 Global Circulating Tumor Cell Market Forecast by Type (2018-2023)

10.3 CTC Enrichment Revenue Growth Rate (2013-2023)

10.4 CTC Detection Revenue Growth Rate (2013-2023)

10.5 CTC Analysis Revenue Growth Rate (2013-2023)

11 Global Circulating Tumor Cell Market Segment by Application

11.1 Global Circulating Tumor Cell Revenue Market Share by Application (2013-2018)

11.2 Circulating Tumor Cell Market Forecast by Application (2018-2023)

11.3 Breast Cancer Revenue Growth (2013-2018)

11.4 Prostate Cancer Revenue Growth (2013-2018)

11.5 Colorectal Cancer Revenue Growth (2013-2018)

11.6 Other Revenue Growth (2013-2018)

12 Global Circulating Tumor Cell Market Size Forecast (2018-2023)

12.1 Global Circulating Tumor Cell Market Size Forecast (2018-2023)

12.2 Global Circulating Tumor Cell Market Forecast by Regions (2018-2023)

12.3 North America Circulating Tumor Cell Revenue Market Forecast (2018-2023)

12.4 Europe Circulating Tumor Cell Revenue Market Forecast (2018-2023)

12.5 Asia-Pacific Circulating Tumor Cell Revenue Market Forecast (2018-2023)

12.6 South America Circulating Tumor Cell Revenue Market Forecast (2018-2023)

12.7 Middle East and Africa Circulating Tumor Cell Revenue Market Forecast (2018-2023)

13 Research Findings and Conclusion

14 Appendix

14.1 Methodology

14.2 Data Source

List of Tables and Figures

Figure Circulating Tumor Cell Picture

Table Product Specifications of Circulating Tumor Cell

Table Global Circulating Tumor Cell and Revenue (Million USD) Market Split by P